Related Articles

• 'Virtual’ Incubator Aims to Pair Startups with Resources
• 2009 Top 10 Innovations
• Administration Unveils Strategy for Health Emergencies
• Arena’s Obesity Drug Trial Shows Patients Lose Moderate Amount of Weight
• BioMarin, Buck Institute Join Forces for Alzheimer’s Research
• Biomedical Companies Sharing Data to Speed Development of Therapies
• Biomedical Industry Becomes Increasingly Vital to State's Economic Stability, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biomedical Industry Jobs Critical to California’s Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biotech Industry Attracts the Most Venture Capital
• Body Clock Drug Offers Hope for Treating Jet Lag, Depression
• California Biomedical Community Honors Congresswoman Anna Eshoo
• California Healthcare Institute Supports Introduction of Biosimilars Legislation
• California Scientists Sound Alarms About National Institutes of Health
• Cancer Major Focus of R&D Efforts in California, but Cures Hard to Come By
• Celebrating Global and Local Biotech Breakthroughs in San Diego
• Celera's Blood Test May Diagnose Lung Cancer
• Cepheid Test Detects TB Within Two Hours
• Cephied Receives FDA Clearance to Market First-ever Molecular Testing Device
• CHI Announces Dr. Topol as Keynote Speaker
• CHI Blog Interviews Mark Smith, M.D., President and CEO of California HealthCare Foundation, Speaker at the 2009 California Healthcare Policy Forum
• CHI Blog: Executive Spotlight: Melinda Richter, Executive Director, San Jose BioCenter
• CHI in Washington, D.C.: Inform. Innovate. Inspire.
• CHI Interviews Mireille Gingras, Ph.D., President and CEO of HUYA Biosciences International
• CHI Joins Coalition in Support of National Pedigree Standard
• CHI Launches Podcast to Help Entrepreneurs Find New Sources of Funding
• CHI Members Called to Help Combat Swine Flu
• CHI Patient Perspectives Podcast Series New Episode: A New Model for Funding Research
• CHI Patient Perspectives Podcast Series New Episode: Finding a Cure: Duchenne
• CHI Patient Perspectives Podcast Series Premieres
• CHI Recognizes National Lab Day Today
• CHI Reporting from 2009 BIO Convention in Atlanta
• CHI to Launch 2010 California Biomedical Industry Report Feb. 2 in Sacramento
• CHI's First-Ever Environmental Summit - March 1 Deadline - Act Fast!
• CHI's Inaugural Environmental Summit Brings Robust Debate and Dialogue
• CIRM Seeks to Protect Exclusivity for Biosimilars
• City of Hope Receives FDA Approval to Conduct First Clinical Study of Stem Cell-Based Therapy
• Commentary: We Need a Science White House
• Congress Works to Resolve Differences in Healthcare Reform Bills
• Congressman Jerry McNerney to Join CHI for Roundtable in Washington, D.C.
• Consumer Genetics Industry to Face Regulatory Changes
• Cutting-edge Medical Technologies Showing Promise in the HIV/AIDS Fight
• Devising an Early Attack on Alzheimer’s
• Diabetes Education Event Will Present Revolutionary New Treatments and Research to Battle California's Seventh Leading Killer
• Diabetes: Bay Area companies fighting epidemic
• Disease-Causing Genes Once Beneficial, Stanford Researchers Say
• Double-Therapy Approach Stopped Brain Cancer Recurrence
• Drug Libraries May Help Discover New Treatments
• Early Bird Registration Now Available for The Healthcare Policy Forum-Innovation at a Crossroads
• Editorial: Complexity of Biotech Drugs Means Copying Them is Risky(2)
• Executive Spotlight: CardioDX Founder and CEO Speaks About Personalizing Cardiovascular Treatments
• Executive Spotlight: Corventis CEO Speaks with CHI About New Technology to Address Most Expensive Ailment
• Executive Spotlight: Mickey Urdea, Ph.D., Chairman, CEO and Founder of Tethys Bioscience
• Executive Spotlight: Pierre Cassigneul, President and CEO, XDx
• Exelixis Drug Works Against Brain Cancer
• FDA and NIH Pledge Clear Path For Personalized Medicine
• FDA May Support New Testing Method for Drugs
• FDA Suggests 510(k) Review to Be Released Soon
• FDA to Aid Tropical Disease Research
• FDA Unveils First Major Nanotech Plan
• Findings Show Promise for Alzheimer’s Detection
• Former House Majority Leader Touts the Impact of Biomed Industry
• Gel Shows Promise for Cutting H.I.V. Infection Rates in African Women
• Genentech Cancer Drug Approved for Kidney Cancer
• Genentech Gains Approval for New Indication For Lucentis
• Genetic Test Helps Prognosis for Patients with Colon Cancer
• Gen-Probe Collaboration on New Diagnostic Systems
• Gen-Probe Says Business is Good
• Gilead’s Drug Trial Shows Half of Patients Successfully Lowered Blood Pressure
• Good News for 18 million Americans Struggling with Obstructive Sleep Apnea
• Growth Industry in California
• IBM, Roche to Build Gene Machine
• Insufficient Sleep: A Growing Problem Among Americans
• July a Landmark Month for FDA: Meetings to Change Landscape for Industry
• Justice Department Seeks Stem-Cell Ruling Stay
• Last Chance To Register Today For FDA 510(k) Event
• Life Sciences Firms to Get Boost from New Federal Program
• Life Sciences Industry Applauds Jerry Hill's Appointment to Chair Biotechnology Committee
• Media - California’s Biomedical Industry is ‘Recession Resilient’
• Media: California’s Biomedical Industry is ‘Recession Resilient’
• Medtronic Launches Bone Cement
• MIT Seeking Nominees $500,000 Prize
• Nanotechnology New Area of Research for Cancer Therapy
• Navigenics and Scripps to Team Up to Study Patient Behavior
• New Approach to H.I.V. Vaccine Offered
• New Breast Cancer Diagnostic Tests Introduced
• New CHI Blog Interview with Joshua Makower, ExploraMed
• New Deals Energize Biotech Sector
• New Guidelines Could Lead to Earlier Alzheimer’s Detection
• New Heart Devices Transmit Information to Physicians
• New HIV Therapy Boosts Immune Systems
• New Pediatric Cancer Research Center Opens in San Diego
• NEW PODCAST: CHI Patient Perspectives Podcast Series: New Approaches to Treatment Needed in Pediatric Cancer
• New report finds stagnant NIH funding shackling young researchers
• New Research Center to Launch at Stanford University
• New Test Approved for Early HIV Detection
• New test predicts risk of post-surgery kidney injury
• New Treatment Option for Prostate Cancer Patients
• NIH Doles Out $400K for Heart-Related MiRNA Research
• Non-Hodgkin's cancer patients living longer according to new study
• Non-Profit Foundations Funding Research on “Orphan Diseases”
• OncoMed and Bayer in Strategic Stem Cell Collaboration
• Onyx Begins Phase 3 Trial Testing Multiple Myeloma Treatment
• Onyx Says Drug Candidate Slows Cancer
• Opinion: To jump-start recovery, innovate
• Orexigen Signs $1B Deal with Takeda on Obesity Drug
• Patients Share Their Stories at the 2010 California Biomedical Industry Report Launch Feb. 2 in Sacramento
• PBS to Air Three-Part Series on Rare Disease Diagnosis through Technology
• Pfizer Abandons Plans to Build Biotech Research Center in San Francisco
• Pfizer Expands Into Rare Diseases with FoldRx Buy
• Pfizer To Focus on Rare Diseases
• PODCAST: Personalized Medicine is Transforming Healthcare
• Presidential Council Suggests Changes to Speed Vaccine Production
• Protein Detected in Brain Might Shed Light on Alzheimer's
• Proteus Biomedical Prescribes 'Smart Pill'
• Proteus Biomedical: Smart Pills the Wave of the Future
• Redefining Disease May Aid in Better Diagnostics, Therapies
• Registration Deadline Tomorrow For FDA 510(k) Event
• Report Calls Private Sector Funding 'Critical' to Biomedical Innovation
• Report Shows the Medical Technology Industry is Strong Contributor to U.S. Economy
• Report: Diagnostic Tests Are Crucial to Health Reform
• Restoring Our Innovative Edge
• Reversing California's Downward Trend: OpEd by Carl Hull, Gen-Probe Incorporated
• Roche Melanoma Drug Shrinks Tumors in 80% of Patients
• Roche Offers $43.7 Billion for Rest of Genentech
• Roche Unveils New Cancer Drug Data
• Salk to Lead $21 Million AIDS Study
• San Diego Biotechs Receive Stem Cell Grants
• Sanford-Burnham Study Finds Cancer Fighting Potential in Painkiller
• Sangamo Upbeat on Drug for Diabetic Nerve Damage
• Scripps, Sanofi to Collaborate on Personalized Medicine
• Sequenom to Expand in Michigan
• Silicon Valley Biomedical Sector is Growing Despite Recession
• Speakers Announced for Environmental Summit
• Sponsorship Deadline March 6 for Celebration of California Biomedical Innovation Event in D.C.
• SRI International Chief: Healthcare Experiencing Biggest Transformation in History
• SRI, Stanford Partner to Drive New Device Offerings
• Stanford Researchers Receive Grants for Stem Cell Research
• Stanford Scientists Discover Stem Cell Advance for Stroke Treatment
• Stanford University to Offer New Genotyping Class
• Stem Cell Therapy Breakthrough May Have Implications for Major Diseases
• Study: U.S. at Risk of Losing Global Lead in Medical Innovation
• Taxation and Healthcare Reform: The Impact on Innovation
• The Future of Personalized Medicine
• The Jobs Tax Officially Qualifies for the November Ballot
• The National Cancer Institute Cancer Human Biobank (caHUB) Public Information Meeting
• Three San Diego Companies Battle Obesity
• TSRI Researchers Discover Potential Drug Targets for Sepsis
• Turning Personalized Medicine into Reality
• U.S. Earns Highest Ranking Among World Biotech Leaders
• UC Davis Researcher Awarded Grant to Explore Nanotechnology Cancer-Fighting Technique
• UC San Diego Earns Top Ranking
• UCI Home to New Stem Cell Research Hub
• UCSD Forms New Medical Engineering Institute
• UCSD Researchers Devise Solution to Sticky Heart Sensor Problem
• UCSD Researchers Report Success with Wireless Glucose Monitor
• UCSD Will Use $37.2 Million Grant for Translating Research into Treatments
• UCSD Wins $10 Million for Schizophrenia Research
• UCSF and Genentech Work Together on Neurodegenerative Diseases
• UCSF Stem Cell Researcher Receives International Award
• University of California to Undertake Groundbreaking Breast Cancer Study
• Vaccine Disparity Points to Need for Better Reimbursement
• Warning Over Drug Trial's Effects on Testing
• Webcast Now Available: 2010 California Biomedical Industry Report
• Wyeth Shares Rise on Promising Study of Alzheimer's Drug